Back to search
Anti-Psychotic
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Anti-Psychotic trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Anti-Psychotic trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study aims to illuminate the biological underpinnings of negative symptoms in schizophrenia-particularly motivational impairments-by probing the link betwe…
Previous study found that some NMDA-enhancing agent was able to augment efficacy of clozapine for clinical symptoms but not cognitive function in the treatment…
Previous studies found that some NMDA-enhancing agents were able to improve clinical symptoms of patients with chronic schizophrenia. In addition, several drugs…
This study purpose is to conduct a confirmatory double-blind randomized controlled trial in an inpatient setting of the effects of a tightly controlled gluten-f…
Negative symptoms and cognitive deficits are two partially-related features of schizophrenia which have a major negative impact on social function and objective…